Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Maximilian Fleischmann · SciRah

Researcher profile · Semantic Scholar

Maximilian Fleischmann

Share profile

Maximilian Fleischmann — researcher profile on SciRah

h-index: 14
Works: 39
Citations: 749

Most-cited papers

Inflammatory fibroblasts mediate resistance to neoadjuvant therapy in rectal cancer.
Adele M. Nicolas, M. Pesic, Esther Engel, Paul K. Ziegler +22 more
2022Cancer Cell290 citations Open access
Semantic Scholar
Molecular Mechanisms of Resistance to FLT3 Inhibitors in Acute Myeloid Leukemia: Ongoing Challenges and Future Treatments
Sebastian Scholl, Maximilian Fleischmann, U. Schnetzke, F. Heidel
2020Cells66 citations Open access
Semantic Scholar
Management of Acute Myeloid Leukemia: Current Treatment Options and Future Perspectives
Maximilian Fleischmann, U. Schnetzke, A. Hochhaus, Sebastian Scholl
2021Cancers51 citations Open access
Semantic Scholar
Molecular Markers to Predict Prognosis and Treatment Response in Uterine Cervical Cancer
Maximilian Fleischmann, G. Chatzikonstantinou, E. Fokas, J. Wichmann +5 more
2021Cancers38 citations Open access
Semantic Scholar
Advances in molecular targeted therapies to increase efficacy of (chemo)radiation therapy
K. Viktorsson, T. Rieckmann, Maximilian Fleischmann, M. Diefenhardt +2 more
2023Strahlentherapie und Onkologie (Print)24 citations Open access
Semantic Scholar
C-Reactive Protein to Albumin Ratio as Prognostic Marker in Locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiotherapy
A. Frey, D. Martin, L. D'Cruz, E. Fokas +2 more
2022Biomedicines24 citations Open access
Semantic Scholar
Outcome of FLT3-ITD-positive acute myeloid leukemia: impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment
Maximilian Fleischmann, U. Schnetzke, K. Schrenk, Volker Schmidt +4 more
2017Journal of Cancer Research and Clinical Oncology24 citations Open access
Semantic Scholar
ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group
Maximilian Fleischmann, M. Diefenhardt, Adele M. Nicolas, F. Rödel +5 more
2022Clinical and Translational Radiation Oncology23 citations Open access
Semantic Scholar
Impact of FLT3-ITD diversity on response to induction chemotherapy in patients with acute myeloid leukemia
M. Fischer, U. Schnetzke, Bärbel Spies-Weisshart, M. Walther +4 more
2017Haematologica23 citations Open access
Semantic Scholar
Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia
Maximilian Fleischmann, Sebastian Scholl, Jochen J. Frietsch, I. Hilgendorf +6 more
2021Journal of Cancer Research and Clinical Oncology21 citations Open access
Semantic Scholar
Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia
Romy Tober, U. Schnetzke, Maximilian Fleischmann, O. Yomade +6 more
2022Journal of Cancer Research and Clinical Oncology20 citations Open access
Semantic Scholar
Impact of body-mass index on treatment and outcome in locally advanced rectal cancer: A secondary, post-hoc analysis of the CAO/ARO/AIO-04 randomized phase III trial.
M. Diefenhardt, E. Ludmir, R. Hofheinz, M. Ghadimi +4 more
2021Radiotherapy and Oncology19 citations
Semantic Scholar
Persistent Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Rectal Cancer
M. Diefenhardt, D. Martin, R. Hofheinz, M. Ghadimi +3 more
2024JAMA Network Open16 citations Open access
Semantic Scholar
Customized 3D‐printed molds for high dose‐rate brachytherapy in facial skin cancer: First clinical experience
G. Chatzikonstantinou, M. Diefenhardt, Maximilian Fleischmann, M. Meissner +6 more
2023Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG16 citations Open access
Semantic Scholar
Overall Survival After Treatment Failure Among Patients With Rectal Cancer
M. Diefenhardt, D. Martin, Maximilian Fleischmann, R. Hofheinz +3 more
2023JAMA Network Open14 citations Open access
Semantic Scholar
Image-guided high-dose-rate brachytherapy for rectal cancer: technical note and first clinical experience on an organ-preserving approach
Maximilian Fleischmann, M. Diefenhardt, Martin Trommel, C. Scherf +5 more
2022Strahlentherapie und Onkologie (Print)13 citations Open access
Semantic Scholar
Modulation of FLT3-ITD Localization and Targeting of Distinct Downstream Signaling Pathways as Potential Strategies to Overcome FLT3-Inhibitor Resistance
Maximilian Fleischmann, Michael Fischer, U. Schnetzke, C. Fortner +4 more
2021Cells11 citations Open access
Semantic Scholar
Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignancies
Katharina Sieker, Maximilian Fleischmann, Martin Trommel, U. Ramm +6 more
2022Strahlentherapie und Onkologie (Print)10 citations Open access
Semantic Scholar
Radioimmunotherapy: future prospects from the perspective of brachytherapy
Maximilian Fleischmann, M. Glatzer, C. Rödel, N. Tselis
2021Journal of Contemporary Brachytherapy9 citations Open access
Semantic Scholar
Association of Polo-Like Kinase 3 and PhosphoT273 Caspase 8 Levels With Disease-Related Outcomes Among Cervical Squamous Cell Carcinoma Patients Treated With Chemoradiation and Brachytherapy
Maximilian Fleischmann, D. Martin, Samuel Peña-Llopis, J. Oppermann +9 more
2019Frontiers in Oncology8 citations Open access
Semantic Scholar
Advantages of 3D printed patient-individual moulds in brachytherapy for facial skin cancer
J. Licher, Julia Achenbach, Janett Köhn, M. Diefenhardt +5 more
2025Strahlentherapie und Onkologie (Print)6 citations Open access
Semantic Scholar
Development and Validation of a Predictive Model for Toxicity of Neoadjuvant Chemoradiotherapy in Rectal Cancer in the CAO/ARO/AIO-04 Phase III Trial
M. Diefenhardt, D. Martin, E. Ludmir, Maximilian Fleischmann +8 more
2022Cancers6 citations Open access
Semantic Scholar
Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy
Regina Mühleck, Sebastian Scholl, I. Hilgendorf, K. Schrenk +7 more
2021Journal of Cancer Research and Clinical Oncology6 citations Open access
Semantic Scholar
Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia
Maximilian Fleischmann, U. Schnetzke, Jochen J. Frietsch, H. Sayer +6 more
2021Journal of Cancer Research and Clinical Oncology6 citations Open access
Semantic Scholar
Prognostic Impact of Caspase-8, CDK9 and Phospho-CDK9 (Thr 186) Expression in Patients with Uterine Cervical Cancer Treated with Definitive Chemoradiation and Brachytherapy
Maximilian Fleischmann, R. Mandal, I. Kostova, M. Raab +7 more
2022Cancers3 citations Open access
Semantic Scholar
ACO/ARO/AIO-22 – External beam radiotherapy combined with endorectal high-dose-rate brachytherapy in elderly and frail patients with rectal cancer: A prospective multicentre trial of the German Rectal Cancer Study Group
H. Dapper, Maximilian Fleischmann, N. Tselis, M. Diefenhardt +32 more
2025Clinical and Translational Radiation Oncology2 citations Open access
Semantic Scholar
Tumor Response and Its Impact on Treatment Failure in Rectal Cancer: Does Intensity of Neoadjuvant Treatment Matter?
M. Diefenhardt, D. Martin, Maximilian Fleischmann, R. Hofheinz +3 more
2024Cancers2 citations Open access
Semantic Scholar
Organ Preservation and Quality of Life After Total Neoadjuvant Treatment in Rectal Cancer
M. Diefenhardt, Emmanouil Fokas, R. Kosmala, Bülent Polat +16 more
2026JAMA Network Open1 citations Open access
Semantic Scholar
Emerging advances and future opportunities in the molecular and therapeutic landscape of anal cancer
F. Rödel, Maximilian Fleischmann, M. Diefenhardt, H. Dapper +4 more
2025Nature Reviews Clinical Oncology1 citations
Semantic Scholar
Total neoadjuvant therapy for rectal cancer: where are we now, where do we go?
Maximilian Fleischmann, Alexander Kristen, M. Diefenhardt, Emmanouil Fokas +1 more
2026Clinical and Translational Radiation Oncology0 citations Open access
Semantic Scholar
Image-guided high-dose-rate brachytherapy after short-course external beam radiotherapy for elderly/frail rectal cancer patients.
Alexander Kristen, N. Tselis, M. Diefenhardt, A. Wiegering +8 more
2026Strahlentherapie und Onkologie (Print)0 citations Open access
Semantic Scholar
3023 Heterogeneity of TNT in rectal cancer - A post-hoc analysis on individual quality of life in disease-free patients in the CAO/ARO/AIO-12 trial
M. Diefenhardt, Maximilian Fleischmann, D. Martin, C. Rödel +1 more
2025Radiotherapy and Oncology0 citations
Semantic Scholar
322: Significance of persistent lymph node metastase after neoadjuvant chemoradiotherapy in rectal cancer
M. Diefenhardt, D. Martin, R. Hofheinz, M. Ghadimi +3 more
2024Radiotherapy and Oncology0 citations
Semantic Scholar
1150: Final Results of the CAO/ARO/AIO-12 trial – A Generalized Pairwise Comparison
M. Diefenhardt, D. Martin, R. Hofheinz, M. Ghadimi +3 more
2024Radiotherapy and Oncology0 citations
Semantic Scholar
2994: Neoadjuvant Chemoradiation for Oral Squamous Cell Carcinoma: The Prospective Phase II INVERT Trial
Maximilian Fleischmann, Alexander Kristen, P. Thönissen, Ria Winkelmann +11 more
2024Radiotherapy and Oncology0 citations
Semantic Scholar
PB1774: PHARMACOLOGICAL STRATEGIES TO OVERCOME RESISTANCE IN AML CELL LINE MODELS HARBORING ACTIVATING FLT3-ITD AND PTPN11 MUTATIONS
Maximilian Fleischmann, N. Urban, Ole Hansen, U. Schnetzke +4 more
2023HemaSphere0 citations Open access
Semantic Scholar
P474: FUNCTIONAL (PHOSPHO-)PROTEOMICS OF DRUG RESPONSE IN ACUTE MYELOID LEUKEMIA
Denys Oliinyk, Maximilian Fleischmann, Dilfuza Ernafasova, Caroline Tschernjawski +3 more
2023HemaSphere0 citations Open access
Semantic Scholar
PH-0111 Impact of body-mass index on multimodal treatment and outcome in locally advanced rectal cancer
M. Diefenhardt, E. Ludmir, R. Hofheinz, M. Ghadimi +4 more
2021Radiotherapy and Oncology0 citations
Semantic Scholar
Risk stratification by anamnesis increases SARS-CoV-2 test efficiency in cancer patients
C. Arnold, J. von der Grün, Mark Christoph Brekner, J. Licher +3 more
2021Strahlentherapie und Onkologie (Print)0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Rödel×27
Invite
C. Rödel — researcher profile on SciRah
M. Diefenhardt×23
Invite
M. Diefenhardt — researcher profile on SciRah
M. Ghadimi×12
Invite
M. Ghadimi — researcher profile on SciRah
E. Fokas×11
Invite
E. Fokas — researcher profile on SciRah

Sebastian Scholl

×11

Invite

Sebastian Scholl — researcher profile on SciRah

Invite

D. Martin — researcher profile on SciRah

U. Schnetzke×10

Invite

U. Schnetzke — researcher profile on SciRah

Invite

F. Rödel — researcher profile on SciRah

Invite

A. Hochhaus — researcher profile on SciRah

Emmanouil Fokas×8

Invite

Emmanouil Fokas — researcher profile on SciRah

Invite

R. Hofheinz — researcher profile on SciRah

Invite

N. Tselis — researcher profile on SciRah